I am a PhD candidate at the Roslin Institute, University of Edinburgh, where I focus on the molecular mechanisms driving osteoclast dysregulation leading to bone invasion in cancer. My research delves into the tumour-bone microenvironment, with particular emphasis on the secretome of cancer cells — cytokines, chemokines, and growth factors that disrupt normal bone homeostasis. By investigating how these factors promote osteoclast activation and bone resorption, I aim to unravel the vicious cycle between tumour and bone cells that drives bone invasion in both human and veterinary oncology. I earned my DVM and MPhil in Physiology (both with Summa Cum Laude), where I investigated signalling pathways in non-small cell lung carcinomas, deepening my understanding of cancer biology and its molecular landscape. My current work integrates oncology and bone biology to identify novel therapeutic targets that could disrupt cancer-induced bone invasion. By bridging veterinary oncology, human cancer research, and bone biology, my goal is to advance translational research and develop therapeutic interventions for both human and animal cancer patients.